Close

Kura Oncology (KURA): Positive Phase II Data on tipifarnib - Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. NFLX
4. CSX
5. SPY
6. UAL
7. ALK
8. EFX
9. TSLA
10. MU


Go back to Kura Oncology (KURA): Positive Phase II Data on tipifarnib - Oppenheimer
(NASDAQ: KURA) Delayed: 17.68 -0.31 (1.72%)
Previous Close $17.99    52 Week High $8.90 
Open $17.86    52 Week Low $2.50 
Day High $18.05    P/E N/A 
Day Low $17.52    EPS $0.00 
Volume 1,703,399